NIEUWS
Quality by Design pilot
In the near future process development for new (bio)pharmaceuticals has to be based upon a Quality by Design (QbD) approach. This means that the process for the new products is controlled in such a way that the process will result in a product with the defined characteristics.
To allow Dutch companies to become acquainted with this new approach a pilot project will start in which a number of companies together explore the implications of Quality by Design on their processes. This pilot project is run by the QbD committee of BioFarmind in close collaboration with the Life Sciences & Health Innovation Program. To know more about this pilot, please contact Coen Beuvery, info@pat-consultancy.com
Bron: lifesciencehealth.com
